Dr. Lichtin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
9500 Euclid Ave
Cleveland, OH 44195Phone+1 800-223-2273
Education & Training
- University of Pennsylvania Health SystemFellowship, Hematology and Medical Oncology, 1983 - 1986
- Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Internal Medicine, 1980 - 1983
- University of Cincinnati College of MedicineClass of 1980
Certifications & Licensure
- OH State Medical License 1982 - 2026
- MI State Medical License 2002 - 2021
- CA State Medical License 2003 - 2020
- PA State Medical License 1983 - 2016
- IL State Medical License 2002 - 2005
- NY State Medical License 2002 - 2005
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011, 2013
- Top MD Consumers Checkbook
Publications & Presentations
PubMed
- 9 citationsFrequency and perturbations of various peripheral blood cell populations before and after eculizumab treatment in paroxysmal nocturnal hemoglobinuria.Carmelo Gurnari, Amy C Graham, Alexey Efanov, Simona Pagliuca, Jibran Durrani
Blood Cells, Molecules & Diseases. 2021-03-01 - 1 citationsSevere thrombocytopenia in a patient with otherwise asymptomatic COVID-19.Lauren M. Granat, Achintya D. Singh, Matthew J Cortese, Vicente Jose M. Velez, Alan E. Lichtin
Cleveland Clinic Journal of Medicine. 2021-02-01 - 10 citationsImplication of PIGA genotype on erythrocytes phenotype in Paroxysmal Nocturnal Hemoglobinuria.Carmelo Gurnari, Simona Pagliuca, Bhumika J. Patel, Hassan Awada, Sunisa Kongkiatkamon
Leukemia. 2021-01-22
Abstracts/Posters
- Feedback Responses of the Pyrimidine Metabolism Network Mediate Resistance to Decitabine and 5-AzacytidineAlan Lichtin, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Long-Term Experience with Large Granular Lymphocytic Leukemia Evolving after Solid Organ and Hematopoietic Stem Cell TransplantationAlan Lichtin, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Extended Experience with a Very Low Dose, Metronomic, Subcutaneous Decitabine Regimen Intended to Deplete DNMT1 without CytotoxicityAlan Lichtin, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Join now to see all
Press Mentions
- ASH Recommends Changes to Continuing Board CertificationMarch 1st, 2019
- 6 Signs You Might Have This Rare Bruising and Bleeding DisorderDecember 14th, 2017
- ASH 2018: Dec 1-4December 1st, 2017
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: